HKIM
AVXL icon

Hayek Kallen Investment Management’s Anavex Life Sciences AVXL Stock Holding History

Hayek Kallen Investment Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$145K Buy
+47,109
New +$204K 0.05% 91
2025
Q4 		– Sell
-12,103
Closed -$108K – 102
2025
Q3 		$108K Hold
12,103
– – 0.03% 94
2025
Q2 		$112K Buy
12,103
+201
+2% +$1.72K 0.04% 94
2025
Q1 		$102K Hold
11,902
– – 0.04% 91
2024
Q4 		$128K Buy
11,902
+39
+0.3% +$300 0.05% 89
2024
Q3 		$67K Hold
11,863
– – 0.02% 93
2024
Q2 		$50K Buy
11,863
+540
+5% +$2.18K 0.02% 91
2024
Q1 		$58K Buy
11,323
+650
+6% +$3.66K 0.02% 91
2023
Q4 		$99K Buy
+10,673
New +$73.5K 0.04% 85

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Hayek Kallen Investment Management's AVXL Position: Q1 2026 in Review

Hayek Kallen Investment Management opened a new position in Anavex Life Sciences (AVXL) in Q1 2026: 47,109 shares worth $145K. The stake represents 0.05% of the portfolio and ranks #91 among its holdings. This is a return to the name: Hayek Kallen Investment Management previously reported a position in AVXL as recently as Q3 2025.

Hayek Kallen Investment Management first reported a position in AVXL in Q4 2023 and has held it in 9 quarters since. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Hayek Kallen Investment Management held 47,109 shares of Anavex Life Sciences worth $145K as of Q1 2026.
  • Anavex Life Sciences was a new Hayek Kallen Investment Management position in Q1 2026.
  • Anavex Life Sciences made up 0.05% of Hayek Kallen Investment Management's portfolio in Q1 2026, its #91 holding.
  • Hayek Kallen Investment Management first reported a position in Anavex Life Sciences in Q4 2023 and has held it in 9 quarters since.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Hayek Kallen Investment Management's 13F filing for Q1 2026, filed 15 May 2026.